| 000 | 01827 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515084211.0 | ||
| 264 | 0 | _c20080211 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a0946-2716 | ||
| 024 | 7 |
_a10.1007/s00109-007-0255-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSommer, W H | |
| 245 | 0 | 0 |
_aPlasticity and impact of the central renin-angiotensin system during development of ethanol dependence. _h[electronic resource] |
| 260 |
_bJournal of molecular medicine (Berlin, Germany) _cOct 2007 |
||
| 300 |
_a1089-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdaptation, Physiological |
| 650 | 0 | 4 |
_aAlcoholism _xdrug therapy |
| 650 | 0 | 4 |
_aAngiotensin II _xdrug effects |
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacology |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aAngiotensinogen _xbiosynthesis |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Genetically Modified |
| 650 | 0 | 4 |
_aCentral Nervous System _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnalapril _xanalogs & derivatives |
| 650 | 0 | 4 |
_aEthanol _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuronal Plasticity _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Antisense _xbiosynthesis |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Angiotensin _xdrug effects |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xdrug effects |
| 700 | 1 | _aRimondini, R | |
| 700 | 1 | _aMarquitz, M | |
| 700 | 1 | _aLidström, J | |
| 700 | 1 | _aSiems, W-E | |
| 700 | 1 | _aBader, M | |
| 700 | 1 | _aHeilig, M | |
| 773 | 0 |
_tJournal of molecular medicine (Berlin, Germany) _gvol. 85 _gno. 10 _gp. 1089-97 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00109-007-0255-5 _zAvailable from publisher's website |
| 999 |
_c17352168 _d17352168 |
||